Literature DB >> 32900354

Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.

Sachin Sharma1, Arshdeep Singh1, Sahil Sharma2, Ram Sharma1, Jagjeet Singh3, Nihar Kinarivala2, Kunal Nepali1, Jing P Liou1.   

Abstract

BACKGROUND: Quinoline is considered to be a privileged heterocyclic ring owing to its presence in diverse scaffolds endowed with promising activity profiles. In particular, quinoline containing compounds have exhibited substantial antiproliferative effects through the diverse mechanism of actions, which indicates that the heteroaryl unit is flexible as well as accessible to subtle structural changes that enable its inclusion in chemically distinct anti-tumor constructs.
METHODS: Herein, we describe a medicinal chemistry perspective on quinolines as anticancer agents by digging into the peer-reviewed literature as well as patents published in the past few years.
RESULTS: This review will serve as a guiding tool for medicinal chemists and chemical biologists to gain insights about the benefits of quinoline ring installation to tune the chemical architectures for inducing potent anticancer effects.
CONCLUSION: Quinoline ring containing anticancer agents presents enough optimism and promise in the field of drug discovery to motivate the researchers towards the continued explorations on such scaffolds. It is highly likely that adequate efforts in this direction might yield some potential cancer therapeutics in the future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Quinoline; anticancer; cell line; cytotoxic; heterocycle; medicinal; scaffold

Mesh:

Substances:

Year:  2021        PMID: 32900354      PMCID: PMC9169701          DOI: 10.2174/1871520620666200908104303

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.527


  63 in total

1.  Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines.

Authors:  S G Alegaon; P Parchure; L D Araujo; P S Salve; K R Alagawadi; S S Jalalpure; V M Kumbar
Journal:  Bioorg Med Chem Lett       Date:  2017-02-22       Impact factor: 2.823

2.  Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

Authors:  Thomas Lindner; Anastasia Loktev; Annette Altmann; Frederik Giesel; Clemens Kratochwil; Jürgen Debus; Dirk Jäger; Walter Mier; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

3.  Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors.

Authors:  Chen Chen; Xuben Hou; Guohua Wang; Wenyan Pan; Xinying Yang; Yingkai Zhang; Hao Fang
Journal:  Eur J Med Chem       Date:  2017-03-28       Impact factor: 6.514

4.  Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.

Authors:  Yong Ling; Qiu-Xing Yang; Yu-Ning Teng; Shi Chen; Wei-Jie Gao; Jing Guo; Pei-Ling Hsu; Yue Liu; Susan L Morris-Natschke; Chin-Chuan Hung; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2018-05-18       Impact factor: 6.514

5.  Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents.

Authors:  Shangze Li; Lihua Hu; Jianru Li; Jiongchang Zhu; Feng Zeng; Qiuhua Huang; Liqin Qiu; Runlei Du; Rihui Cao
Journal:  Eur J Med Chem       Date:  2018-11-22       Impact factor: 6.514

6.  New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.

Authors:  Samar H Abbas; Amer Ali Abd El-Hafeez; Mai E Shoman; Monica M Montano; Heba A Hassan
Journal:  Bioorg Chem       Date:  2018-11-02       Impact factor: 5.275

7.  Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity.

Authors:  Concepción Alonso; María Fuertes; Endika Martín-Encinas; Asier Selas; Gloria Rubiales; Cinzia Tesauro; Birgitta K Knudssen; Francisco Palacios
Journal:  Eur J Med Chem       Date:  2018-02-22       Impact factor: 6.514

8.  Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity.

Authors:  Rasha M Aly; Rabah A T Serya; Amira M El-Motwally; Ahmed Esmat; Safinaz Abbas; Dalal A Abou El Ella
Journal:  Bioorg Chem       Date:  2017-11-05       Impact factor: 5.275

9.  2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.

Authors:  Hsueh-Yun Lee; Chih-Yi Chang; Chih-Jou Su; Han-Li Huang; Samir Mehndiratta; Yuh-Hsuan Chao; Chia-Ming Hsu; Sunil Kumar; Ting-Yi Sung; Yi-Zhen Huang; Yu-Hsuan Li; Chia-Ron Yang; Jing-Ping Liou
Journal:  Eur J Med Chem       Date:  2016-06-16       Impact factor: 6.514

10.  3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties.

Authors:  Clement Opoku-Temeng; Neetu Dayal; Moloud Aflaki Sooreshjani; Herman O Sintim
Journal:  Bioorg Chem       Date:  2018-04-17       Impact factor: 5.275

View more
  1 in total

1.  Cancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug.

Authors:  Ruizhen Ru; Yanzheng Guo; Juanxuan Mao; Zonghe Yu; Wen Huang; Xudong Cao; Huijian Hu; Minjie Meng; Lihong Yuan
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.